The new name highlights the combined capabilities
of decision support expertise and advanced technology solutions
ORLANDO,
Fla., July 30, 2024 /PRNewswire/ -- inPhronesis,
a leading provider of cloud-based technology solutions for the life
sciences industry, announced today that it is changing its name to
inThought Labs. The new name reflects inThought Labs' commitment to
providing innovative and impactful technologies to pharmaceutical
clients.
The parent of inThought Labs, inThought Research Inc., was
founded in 2008 as a strategic partner for biopharma decision
makers, providing expert insights and analysis for business
development, medical affairs, competitive intelligence, market
research, brand, and executive teams. In 2018, inThought Research
launched inPhronesis as a subsidiary to market and develop
inVision. This cloud-based, AI-driven platform was built
specifically for the life sciences industry to enhance efficiency
within biopharmaceutical companies and promote generating and
sharing actionable insights and recommendations.
The flexible, highly customizable inVision platform will remain
the cornerstone of inThought Labs. This platform was built with the
deep domain expertise and industry experience of inThought Research
to offer tailored solutions for competitor monitoring, conference
coverage, pipeline analysis, clinical trial data analysis,
publication planning, valuation modeling, and other solutions
customized to our clients' needs.
The name inThought Labs highlights the increased importance of
AI and other technologies to biopharma decision support, medical
affairs/communications, and business development. It also signals
the conviction that a biopharma technology provider must have an
in-depth understanding of the life science industry and its unique
needs. inThought Labs will continue to develop market-leading
solutions facilitating better insights and decision making.
Importantly, these solutions will meet the compliance and privacy
needs of the biopharmaceutical industry. inVision's cloud-based
system is built on a SOC2 compliant backbone, and its new AI tools
are being built with cutting edge security and privacy checks to
give biopharmaceutical companies the confidence they need to
broadly adopt our solutions.
"We are excited to become inThought Labs, demonstrating our
commitment to excellence and innovation to the life sciences
industry," said Chris Martin,
President of inThought Labs. "By combining our cutting-edge
technology solutions with the unparalleled domain expertise and
industry experience of inThought, we offer our clients a unique and
powerful value proposition that sets us apart from other technology
providers."
For more, please see our new website at
www.inthoughtlabs.com.
About inThought Labs
inThought Labs is a leading provider of cloud-based technology
solutions for the life sciences industry. The company's mission is
to empower biopharma decision makers with innovative and impactful
technologies that enhance the efficiency and effectiveness of
biopharma decision support, medical communications, and business
development. The company's flagship product is the inVision
platform, a cloud-based solution that integrates multiple data
sources and applies advanced analytics and artificial intelligence
to facilitate generating actionable insights and recommendations.
For more information, please visit www.inthought.com.
About inThought Research
inThought Research is a premier life science advisory firm that
provides expert insights and analysis on a wide range of topics,
such as competitive intelligence, market research, medical affairs,
and business development. For more information, please visit
www.inthought.com.
Contact information
Haley Sellers
hsellars@inthoughtlabs.com
(804) 878-6900
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inphronesis-announces-name-change-to-inthought-labs-302210304.html
SOURCE inThought, Inc.